HomeCompareRWCRF vs MRK

RWCRF vs MRK: Dividend Comparison 2026

RWCRF yields 740.74% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RWCRF wins by $1453571.20M in total portfolio value
10 years
RWCRF
RWCRF
● Live price
740.74%
Share price
$0.27
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1453571.26M
Annual income
$1,148,554,802,375.62
Full RWCRF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — RWCRF vs MRK

📍 RWCRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRWCRFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RWCRF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RWCRF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RWCRF
Annual income on $10K today (after 15% tax)
$62,962.96/yr
After 10yr DRIP, annual income (after tax)
$976,271,582,019.28/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, RWCRF beats the other by $976,271,573,690.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RWCRF + MRK for your $10,000?

RWCRF: 50%MRK: 50%
100% MRK50/50100% RWCRF
Portfolio after 10yr
$726785.66M
Annual income
$574,277,406,086.88/yr
Blended yield
79.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RWCRF
No analyst data
Altman Z
-0.3
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RWCRF buys
0
MRK buys
0
No recent congressional trades found for RWCRF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRWCRFMRK
Forward yield740.74%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1453571.26M$56.8K
Annual income after 10y$1,148,554,802,375.62$9,798.13
Total dividends collected$1429127.51M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RWCRF vs MRK ($10,000, DRIP)

YearRWCRF PortfolioRWCRF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$84,774$74,074.07$11,206$366.19+$73.6KRWCRF
2$677,583$586,874.86$12,650$502.35+$664.9KRWCRF
3$5,108,920$4,383,906.23$14,407$694.19+$5.09MRWCRF
4$36,358,402$30,891,856.97$16,585$967.82+$36.34MRWCRF
5$244,367,567$205,464,077.51$19,342$1,363.89+$244.35MRWCRF
6$1,552,071,061$1,290,597,763.76$22,913$1,947.19+$1552.05MRWCRF
7$9,321,534,421$7,660,818,385.65$27,662$2,823.89+$9321.51MRWCRF
8$52,973,917,047$42,999,875,217.43$34,159$4,173.35+$52973.88MRWCRF
9$285,062,106,249$228,380,015,007.86$43,337$6,308.80+$285062.06MRWCRF
10$1,453,571,256,062$1,148,554,802,375.62$56,776$9,798.13+$1453571.20MRWCRF

RWCRF vs MRK: Complete Analysis 2026

RWCRFStock

RIWI Corp. operates as a trend-tracking and prediction technology firm in the United States, Canada, Europe, and internationally. Its patented cloud-based software solution provides global digital intelligence platform to clients seeking real-time citizen sentiment data. The company offers subscription products, such as RIWI compass to gauge the extent of political and geopolitical risks; RIWI Alpha which provides real-time data on consumer demand and purchase signals for electric vehicles and luxury goods; and RIWI high-frequency economic data stream which provides data on consumer intentions, jobs, and personal income in real-time. It also provides data solutions, including RIWI track for custom surveys and continuous trend tracking, measurement, and prediction; RIWI test, a concept, ad, and message testing; RIWI audience to scale online engagement initiatives or platforms; RIWI rapid response, to assess critical situations; and RIWI omnibus to source answers to a few questions using random domain intercept technology. The company serves government and public sector, financial services, healthcare, international development, and consumer service industries. RIWI Corporation was incorporated in 2009 and is headquartered in Toronto, Canada.

Full RWCRF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this RWCRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RWCRF vs SCHDRWCRF vs JEPIRWCRF vs ORWCRF vs KORWCRF vs MAINRWCRF vs JNJRWCRF vs ABBVRWCRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.